|
|
||||||||
Peptide loading of MHC class II molecules
|
TNF-
production by CD8+ T cells
Activation of CD8+ T cells by APC-presented peptide ligands is an important step in control of intracellular pathogens. Although effector CD8+ T cells contribute to the late response to an infection, the observation that intracellular TNF-
accumulates shortly after TCR engagement suggests that activated cells also might impact the early response. Brehm et al. (p. 5043
) detected soluble and membrane-bound TNF-
, but no IFN-
, on CD8+ T cells after stimulation of splenocytes from naive or virus peptide-specific TCR transgenic mice with anti-CD3 mAb or viral peptide, respectively. Only activated CD44high or memory CD8+ T cells produced both TNF-
and IFN-
. TNF-
was detected by one hour of stimulation and levels peaked after 4 h of stimulation; the cytokine was not detected in cells treated with actinomycin D or cycloheximide. Immortalized dendritic cells (DCs) pulsed with the viral peptide and cocultured with naive splenocytes from the virus peptide-specific TCR transgenic mice had increased expression of a MHC class II molecule compared with unpulsed controls. Anti-IFN-
mAb blocked the increase, whereas an inhibitor of murine TNF-
activity further increased the expression but had no effect in the presence of the anti-IFN-
mAb. Pulsed DCs cocultured with the peptide-specific TCR transgenic cells, or unpulsed DCs treated with supernatant from viral peptide-stimulated TCR transgenic cells, had increased MHC class II molecule expression and decreased viability. The authors show that rapid synthesis of TNF-
by stimulated CD8+ T cells impacts the adaptive immune response by altering DC maturation and decreasing DC viability.
Estrogen and DC differentiation
Kovats and collaborators previously used 17
-estradiol (E2) to promote differentiation of two major subsets of dendritic cells (DCs) from mouse bone marrow progenitors in ex vivo cultures containing GM-CSF. In a follow-up to that study, the same laboratory (Mao et al., p. 5146
) functionally characterized those CD11bhighLy6C+ and CD11bintLy6C DC subsets. CD11bintLy6C DCs appeared only in cultures containing E2. As measured by RT-PCR analysis, both subsets contained estrogen receptor
mRNA, but the CD11bhigh Ly6C+ DCs also expressed estrogen receptor
mRNA. Relative expression of MHC (class I or II) molecules, several costimulatory molecules and chemokine receptors, as determined by four-parameter flow cytometry, differed between the two subsets; increased expression of MHC class I and II molecules and CD80, CD83, and CD86 was greater on CD11bintLy6C DCs following LPS activation. However, CD11bhighLy6C+ DCs cells internalized more FITC-labeled molecules during culture with E2. Only CD11bintLy6C DCs expressed langerin mRNA and possessed Birbeck granules, which are cytoplasmic structures detected by electron microscopy in Langerhans cells. The authors conclude that E2 promotes differentiation of Langerhans type epidermal DCs.
NKT cells and allergic asthma
|
24-J
18 rearrangement (V
24+i NKT) can promote Th2 differentiation of T cells during allergic inflammation, the mechanism is unknown. Sen et al. (p. 4914
) found higher surface and intracellular expression of CCR9 in V
24+i NKT cells from patients with allergic asthma than from normal controls; CCL25, the CCR9 ligand, induced chemotaxis only of asthmatic V
24+i NKT cells. More cells positive for CCR9+ and V
24+i were detected immunohistochemically in the submucosa of bronchus biopsies from allergic asthma patients vs healthy subjects. IL-4, IL-13, IL-10, TGF-1
, IL-2, IFN-
, CCL25, and CXCL9 mRNAs were highly up-regulated only in asthmatic bronchus mucosa, and stimulation with
-galactosylceramide further increased expression of IL-2, IL-10, and IFN-
. Asthmatic, but not normal, V
24+i NKT cells were Th1 biased and induced production of IL-4 and IL-13 by syngeneic CD3+ T cells in a contact-dependent manner. Asthmatic V
24+i NKT cells had highest expression of adhesion molecule CD226, which was phosphorylated after treatment of those cells with CCL25 or immobilized anti-CD226 mAb. Treatment of asthmatic V
24+i NKT cells with short hairpin CD226 RNA or anti-CD226 mAb blocked their CCL25-stimulated ability to induce CD3+ T cells to produce Th2 cytokines. Normal V
24+i NKT cells transfected with CCR9 cDNA expressed CCR9 and CD226 at levels comparable to cells from asthma patients; CCR9 and CD226 expression levels were low in V
24+i NKT cells from asthma patients in remission or treated with corticosteroid. Only the transfected and asthmatic cells stimulated Th2 cytokine production by CD3+ T cells. The data demonstrate that allergic asthma is induced by CCR9+CD226+V
24+i NKT cell promotion of Th2 cytokine production by CD3+ T cells. Glycans and colitis
|
and TNF-
in the mAb-treated mice were comparable to those seen in normal mice but were higher in untreated controls. The mAb reduced in vitro production of TNF-
, IL-23, IL-12, and NO from LPS-stimulated macrophages expressing the mAb-reactive epitope. Anti-carboxylated glycan mAb-treated mice did not have the up-regulation of two glycan-binding S100 proteins, their carboxylated glycan-containing receptor, and NF-
B p65 seen at 3 wk post-cell transfer in colonic lamina propria of untreated and control Ab-treated mice. This report identifies NF-
B activation as an important step in mouse colitis pathology following carboxylated glycan/lectin interaction. Bypassing central tolerance
Developing autoreactive B cells are inactivated through receptor editing. This mechanism, coupled with allelic exclusion, usually ensures that a lymphocyte expresses a unique BCR. However, Liu et al. (p. 5067 ) studied the development of B cells coexpressing two BCRs, reactive and nonreactive with membrane-bound H-2Kb, in 3-83Ig knockin (Igi), H-2b mice. Mice developed 3-83IgM autoantibodies by 7 mo of age, although B cells expressing surface 3-83Ig receptors were never detected. <4% of splenic IgM+ B cells in lethally irradiated H-2b mice, adoptively transferred with homozygous or hemizygous 3-83Igi, H-2d bone marrow cells, expressed surface 3-83Ig ex vivo compared with 22% after 2 days of culture in vitro. Anti-3-83IgM Ab was produced by 60 and 43% of B cell hybridomas established from LPS-stimulated spleen cells from 3-83Igi mice, homozygous or hemizygous, respectively, for H-2b. Receptor editing did not occur in B cells in 3-83Igi mice bred onto a Rag1/, H-2b background, resulting in no transitional 1, transitional 2, and mature splenic B cells. In the absence of H-2Kb, B cells from H-2d mice with a second nonautoreactive Igh, in addition to 3-83Igh and Igk, coexpressed BCRs with each Igh paired with 3-83Igk. Approximately 45% of B cells from H-2b mice adoptively transferred with H-2d bone marrow cells carrying 3-83Igi plus the second Igh re-expressed 3-83Ig surface Ab in vitro, compared with 0% of B cells from H-2b mice carrying 3-83Igi plus the second Igh. Surface expression of 3-83Ig on Igh/3-83Igi, H-2b spleen B cells was higher in the presence of a Src family kinase inhibitor, with or without a lysosome inhibitor, during in vitro culturing in the presence of the autoantigen. The data suggest that high avidity autoreactive B cells that escape receptor editing by expressing nonautoreactive Abs can differentiate and survive central tolerance.
In vitro generation of NK cells
|
was seen after stimulation of hESC-derived NK cells with IL-12 plus IL-18. The authors show that they can derive functional lymphoid cells from undifferentiated hESCs and can selectively expand and induce maturation of NK cells. Summaries written by Dorothy L. Buchhagen, Ph.D.
Related articles in The JI:
24-Invariant NKT Cells from Patients with Allergic Asthma Express CCR9 at High Frequency and Induce Th2 Bias of CD3+ T Cells upon CD226 Engagement
following TCR Engagement of Naive CD8 T Cells
B
| ||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |